ClinicalTrials.gg
Sign In

Drug

Elironrasib clinical trials

Also written RMC-6291.

studies test it
3
open now
2
in phase 3
0
first study started
2022

Keep track of what changes. Save the elironrasib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Elironrasib
1

Development codes

RMC-6291
3

Studies by the year they started

3 studies that test it; most in 2022 (1)

Studies that test elironrasib, by start year
YearStudies
20221
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Non-Small-Cell Lung
3

Who runs them

Industry 3 · Other 0

Revolution Medicines, Inc. (3)

Often tested with

Tested in the same studies.

Daraxonrasib (2) · Pembrolizumab (1) · Cisplatin (1) · Carboplatin (1) · Pemetrexed (1) · Zoldonrasib (1)

Studies

Open first, then newest update. How each study uses elironrasib is read from its arms, and is right about nine times in ten.

Testing it · 3

Given in every arm · 1 — elironrasib is usual care beside what is tested

Codes

What other systems call elironrasib · ClinicalTrials.gg INT015781

  • UNII (FDA) 942KVV5CJPELIRONRASIBConfirmed FDA, Wikidata
  • Wikidata Q140529143elironrasibConfirmed FDA, Wikidata
  • NCI Thesaurus C189824ElironrasibOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.